93 related articles for article (PubMed ID: 36650838)
1. The impact of hypertension on the prognosis of patients with hypertrophic cardiomyopathy: a single-center retrospective study.
Wang Z; Zheng Y; Ruan H; Li L; Zhang M; Duan L; He S
PeerJ; 2023; 11():e14614. PubMed ID: 36650838
[TBL] [Abstract][Full Text] [Related]
2. Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy.
He CJ; Zhu CY; Fan HY; Qian YZ; Zhai CL; Hu HL
Clin Cardiol; 2023 Dec; 46(12):1569-1577. PubMed ID: 37711064
[TBL] [Abstract][Full Text] [Related]
3. Prognosis for patients with apical hypertrophic cardiomyopathy: A multicenter cohort study based on propensity score matching.
Ma H; Zhou Y; He Y; Yu C; Liao Q; Xi H; Luo R; Liu M; Tao J; Liu T; Li X
Kardiol Pol; 2023; 81(12):1247-1256. PubMed ID: 38189505
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
Bonaventura J; Rowin EJ; Chan RH; Chin MT; Puchnerova V; Polakova E; Macek M; Votypka P; Batorsky R; Perera G; Koethe B; Veselka J; Maron BJ; Maron MS
J Am Heart Assoc; 2024 May; 13(10):e033565. PubMed ID: 38757491
[TBL] [Abstract][Full Text] [Related]
5. Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathy.
Fumagalli C; Zocchi C; Cappelli F; Celata A; Tassetti L; Sasso L; Zampieri M; Argirò A; Marchi A; Targetti M; Berteotti M; Maurizi N; Mori F; Livi P; Baldini K; Tomberli A; Girolami F; Favilli S; Mecacci F; Olivotto I
Eur J Prev Cardiol; 2024 Jan; 31(1):3-10. PubMed ID: 37531614
[TBL] [Abstract][Full Text] [Related]
6. Prediction of cardiac death in patients with hypertrophic cardiomyopathy using plasma adipokine levels.
Akita K; Hasegawa K; Fifer MA; Tower-Rader A; Jung J; Maurer MS; Reilly MP; Shimada YJ
Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1352-1360. PubMed ID: 38403486
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy.
Li L; Ban C; Ruan H; Zhang M; Wang Z; Ma M; Zheng Y; He S
BMC Cardiovasc Disord; 2023 Nov; 23(1):559. PubMed ID: 37974066
[TBL] [Abstract][Full Text] [Related]
8. Mildly Reduced Renal Function Is Associated With Increased Heart Failure Admissions in Patients With Hypertrophic Cardiomyopathy.
Bae NY; Rhee TM; Park CS; Choi YJ; Lee HJ; Choi HM; Park JB; Yoon YE; Kim YJ; Cho GY; Hwang IC; Kim HK
J Korean Med Sci; 2024 Mar; 39(8):e80. PubMed ID: 38442721
[TBL] [Abstract][Full Text] [Related]
9. Long term mortality in patients with hypertrophic cardiomyopathy - A Danish nationwide study.
Jacobsen MB; Petersen JK; Modin D; Butt JH; Thune JJ; Bundgaard H; Pedersen CT; Køber L; Fosbøl EL; Raja AA
Am Heart J Plus; 2023 Jan; 25():100244. PubMed ID: 38510499
[TBL] [Abstract][Full Text] [Related]
10. Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy.
Liang LW; Raita Y; Hasegawa K; Fifer MA; Maurer MS; Reilly MP; Shimada YJ
Heart; 2022 Oct; 108(22):1807-1814. PubMed ID: 35351822
[TBL] [Abstract][Full Text] [Related]
11. Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades.
Maurizi N; Olivotto I; Maron MS; Bonacchi G; Antiochos P; Tomberli B; Fumagalli C; Poggesi C; Berteotti M; Girolami F; Cecchi F; Maron BJ
JACC Adv; 2023 Jun; 2(4):100337. PubMed ID: 38938243
[TBL] [Abstract][Full Text] [Related]
12. Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy.
Zampieri M; Schoonvelde SAC; Vinci M; Meattini I; Visani L; Fornaro A; Coppini R; Romei A; Marchi A; Morelli I; van Slegtenhorst MA; Palinkas ED; Livi L; Michels M; Olivotto I
Mayo Clin Proc; 2024 Feb; 99(2):218-228. PubMed ID: 38180395
[TBL] [Abstract][Full Text] [Related]
13. The China Hypertrophic Cardiomyopathy Project (CHCMP): The Rationale and Design of a Multicenter, Prospective, Registry Cohort Study.
Du Z; Wang K; Cui Y; Xie X; Zhu R; Dong F; Guo X
J Cardiovasc Transl Res; 2024 Jan; ():. PubMed ID: 38180696
[TBL] [Abstract][Full Text] [Related]
14. Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics.
Lumish HS; Liang LW; Hasegawa K; Maurer MS; Fifer MA; Reilly MP; Shimada YJ
Heart; 2023 Nov; 109(24):1837-1843. PubMed ID: 37451849
[TBL] [Abstract][Full Text] [Related]
15. Machine Learning-Based Discrimination of Cardiovascular Outcomes in Patients With Hypertrophic Cardiomyopathy.
Rhee TM; Ko YK; Kim HK; Lee SB; Kim BS; Choi HM; Hwang IC; Park JB; Yoon YE; Kim YJ; Cho GY
JACC Asia; 2024 May; 4(5):375-386. PubMed ID: 38765660
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Impact of SARS-CoV-2 on Hypertrophic Cardiomyopathy.
Saleh D; Meng Z; Johnson N; Baldridge A; Zielinski AR; Choudhury L
J Cardiovasc Dev Dis; 2024 Mar; 11(4):. PubMed ID: 38667722
[TBL] [Abstract][Full Text] [Related]
17. Clinical course of adults with co-occurring hypertrophic cardiomyopathy and hypertension: A scoping review.
Arabadjian M; Montgomery S; Pleasure M; Nicolas B; Collins M; Reuter M; Massera D; Shimbo D; Sherrid MV
Am Heart J Plus; 2024 Mar; 39():100367. PubMed ID: 38510995
[TBL] [Abstract][Full Text] [Related]
18. Dementia increases the risk of death in stroke patients: A retrospective cohort-based risk score model study.
Su X; Pan D; Meng H; Lu W; Wang X; Liu Z; Geng Y; Ma X; Liang P
J Stroke Cerebrovasc Dis; 2023 Nov; 32(11):107337. PubMed ID: 37677896
[TBL] [Abstract][Full Text] [Related]
19. Follow-up and prognosis of HCM.
Dominguez F; Sanz-Sánchez J; García-Pavía P; Zorio E
Glob Cardiol Sci Pract; 2018 Aug; 2018(3):33. PubMed ID: 30393645
[No Abstract] [Full Text] [Related]
20. Editorial: Cardiovascular genetics-focus on paediatric cardiomyopathy.
Monda E; Kaski JP; Limongelli G
Front Pediatr; 2023; 11():1147527. PubMed ID: 36846159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
